tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Stephen Willey, 155 are a BUY (71.43%), 60 are a HOLD (27.65%), 2 are a SELL (0.92%).
Analyst Stephen Willey, currently employed at STIFEL, carries an average stock price target met ratio of 49.45% that have a potential upside of 32.35% achieved within 184 days.
Stephen Willey’s has documented 398 price targets and ratings displayed on 46 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IGMS, IGM Biosciences at 11-Nov-2024.
Analyst best performing recommendations are on ADGI (ADAGIO THERAPEUTICS).
The best stock recommendation documented was for MGNX (MACROGENICS) at 5/6/2020. The price target of $21 was fulfilled within 1 day with a profit of $4.15 (16.5%) receiving and performance score of 165.01.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$5
$1.52 (43.68%)
$9
2 years 7 months 5 days ago
(13-May-2022)
1/3 (33.33%)
$2.28 (83.82%)
2
Sell
$6
2 years 11 months 5 days ago
(13-Jan-2022)
3/4 (75%)
$-0.12 (-1.96%)
12
Hold
2 years 11 months 20 days ago
(28-Dec-2021)
0/1 (0%)
$26.16 (77.30%)
Buy
$40
3 years 2 days ago
(16-Dec-2021)
1/1 (100%)
$6.16 (18.20%)
3
Which stock is Stephen Willey is most bullish on?
Which stock is Stephen Willey is most reserved on?
What Year was the first public recommendation made by Stephen Willey?
